Introduction
Autoimmune disorders comprise a diverse collection of conditions in which the immune system erroneously targets and damages the body’s own healthy cells, tissues, or organs1. This triggers chronic inflammation and destruction, resulting in significant morbidity. Millions of people are affected by autoimmune diseases globally. An increasing prevalence is noted in women, with female-to-male ratios varying from 3:1 to as high as 9:1 in certain cases, which suggests hormonal and genetic influences2.
In addition to the physical burden, autoimmune diseases often lead to chronic pain, fatigue, disability, and psychological distress, which severely affects the quality of life3. Economically, the complexity of these illnesses puts a substantial strain on healthcare systems and patients owing to the need for prolonged treatment and frequent disease monitoring4.
Pathophysiology
Autoimmune diseases can be broadly divided into organ-specific and systemic disorders. Organ-specific autoimmune diseases cause immune damage that primarily affects a single tissue or organ. Examples include type 1 diabetes mellitus (T1DM), which targets pancreatic islet beta cells, and Hashimoto’s thyroiditis, which affects the thyroid gland5, 6. On the other hand, systemic autoimmune disorders include systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and scleroderma7-9. These impact several organ systems at once and produce complex clinical symptoms.
Some patients have overlap syndromes, showing signs of multiple autoimmune diseases, which can complicate diagnosis and treatment.
Autoimmune diseases often result from failed self-tolerance mechanisms, which normally prevent immune cells from attacking the body’s own tissues10. These disorders vary in terms of immune system targets, the mechanisms involved, and the degree of organ involvement.
Two primary tolerance checkpoints are identified:
- Central tolerance: In the primary lymphoid organs (the thymus for T cells and bone marrow for B cells), self-reactive lymphocyte clones are detected and removed during development11.
- Peripheral tolerance: Self-reactive cells that are not eliminated centrally are suppressed or deactivated through mechanisms such as regulatory cells, inhibitory receptors, and other controls11.
Any failure in these tolerance mechanisms—due to genetic, environmental, or immunological factors—leads to the activation of autoreactive lymphocytes12. These lymphocytes then produce autoantibodies and pro-inflammatory cytokines that initiate and perpetuate tissue inflammation and damage.
Etiology and risk factors
Although the precise causes of autoimmune diseases remain partially understood, their development is influenced by a combination of environmental exposures, hormonal factors, genetic predisposition, and immune dysregulation12.
Genetic predisposition
Certain human leukocyte antigen (HLA) alleles and non-HLA genes increase a person’s susceptibility to autoimmune diseases by influencing antigen presentation and the balance of the immune response. For example, HLA-DR3 and DR4 alleles are associated with T1DM and RA, respectively13, 14.
Environmental triggers
Microbial infections (both viral and bacterial) may induce autoimmunity through mechanisms like molecular mimicry, epitope spreading, or by causing tissue damage that exposes hidden antigens15. Exposure to certain chemicals and medications can also trigger or worsen autoimmune responses16, 17. For example, exposure to ultraviolet radiation may intensify the dermatological symptoms of lupus, while tobacco use has been associated with an increased risk of RA and multiple sclerosis18, 19.
Hormonal influences
Autoimmune disorders are more common in females, which indicates that sex hormones significantly influence immune function20. For instance, estrogens may enhance antibody-mediated immune responses, which can result in greater susceptibility21. Pregnancy and hormonal fluctuations often affect disease activity22.
Immune dysregulation
Failures in regulatory T cell function, abnormal cytokine profiles (such as elevated type I interferons), and faulty immune checkpoints all contribute to persistent autoreactivity23-25.
Clinical Manifestations
Autoimmune diseases are characterized by a wide range of signs and symptoms, which vary according to the particular disorder and the organs affected.
Musculoskeletal
RA, one of the most common autoimmune diseases, is a classic example of inflammatory arthritis characterized by joint pain, swelling, stiffness, and reduced mobility26. Myalgia and muscle weakness are also frequently reported.
Endocrine
The autoimmune destruction or stimulation of endocrine glands causes conditions like Hashimoto’s thyroiditis (hypothyroidism), Graves’ disease (hyperthyroidism), Addison’s disease (adrenal insufficiency), and T1DM (pancreatic beta-cell destruction)5, 27-29.
Hematological
Autoimmune hemolytic anemia occurs when the immune system destroys red blood cells30. Similarly, immune suppression or destruction of white blood cells and platelets can cause leukopenia and thrombocytopenia31.
Cardiovascular
Autoimmune diseases are associated with potential complications in the heart, such as ischemic injuries or cardiac failure32. Examples include inflammation of the heart, such as pericarditis and myocarditis, as well as inflammation of the blood vessels, known as vasculitis.
Systemic symptoms
Common systemic symptoms include fatigue, fever, weight loss, malaise, and cutaneous manifestations like photosensitivity and vasculitic lesions18, 33. Rashes, such as the malar rash seen in lupus, are also common34.
Neurological
This involves peripheral neuropathies and central nervous system disorders, such as multiple sclerosis35.
A thorough clinical assessment, comprehensive history taking, and targeted laboratory investigations are critical for diagnosing autoimmune disorders. Diagnoses are frequently delayed due to the variability and nonspecific presentation of symptoms.
Diagnostic approach
Diagnosis relies on clinical criteria combined with laboratory evidence of autoimmune activity:
- Detection of specific autoantibodies, such as anti-nuclear antibodies, rheumatoid factor, and anti-thyroid antibodies36-38.
- Detection of inflammatory markers, such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)39, 40.
- Imaging studies for organ involvement, such as joint X-rays and MRIs41.
- Biopsy in selected cases, such as the skin and kidney41.
Treatment and management
Owing to the persistent and relapsing nature of autoimmune disorders, diagnosis and treatment are often lifelong. The aim of treatment is to suppress the aberrant immune response, control inflammation, and prevent irreversible organ damage. The goal is also to alleviate symptoms and improve a patient’s quality of life.
Pharmacological therapies
- Anti-inflammatory drugs: These include nonsteroidal anti-inflammatory drugs (NSAIDs), which are prescribed for mild pain and inflammation, and corticosteroids (e.g., prednisone), which are potent anti-inflammatory and immunosuppressive agents often used for acute flares or severe disease42.
- Immunosuppressants: Traditional immunosuppressive drugs like methotrexate, azathioprine, and cyclosporine work by dampening the overall immune response43.
- Biologic agents: This is a newer class of targeted therapies that specifically block certain molecules or cells involved in the autoimmune process, such as TNF inhibitors for RA or B-cell depleting agents for certain lymphomas and autoimmune conditions42, 44.
- Disease-modifying antirheumatic drugs (DMARDs): This category includes some immunosuppressants and biologics that aim to slow disease progression and prevent joint damage in conditions like RA42.
Non-pharmacological management
- Following certain lifestyle modifications such as a balanced diet, participating in regular and suitable physical activity, and using stress management methods may affect symptom levels and overall health45.
- Physical and occupational therapy are crucial for maintaining the mobility, strength, and function of joints and muscles46.
- Pain management strategies may include over-the-counter pain relievers, topical treatments, or referral to pain specialists47.
- Psychological counseling can help patients cope with the chronic nature of the disease and its impact on mental health48.
Effective management requires a multidisciplinary team approach with rheumatologists, endocrinologists, immunologists, and primary care providers collaborating closely.
Prognosis and future directions
Even with better diagnostics and treatments, mortality remains higher for patients with autoimmune diseases. Understanding immune tolerance failure, genetic and environmental factors, and new therapies is crucial to improving care and outcomes.
Emerging research focuses on immunomodulation, personalized medicine, biomarker discovery for early detection and prognosis, and novel therapeutic agents to comprehensively restore immune tolerance49-52.
In summary, autoimmune diseases pose significant clinical and societal challenges due to their complex pathogenesis, diverse manifestations, and chronicity.